Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Links

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Palliative & Supportive Care|February 7, 2015
A preliminary study to develop an intervention to facilitate communication between couples in advanced cancerJane Mowll, Elizabeth A Lobb, Lisbeth Lane, et al.
Asia-Pacific Journal of Clinical Oncology|December 14, 2011
Randomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancerPaul L Mitchell, Adam Broad, Mark A Rosenthal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2016
Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non-Small Cell Lung CancerPei Ni Ding, Sarah J Lord, Val Gebski, et al.
American Journal of Obstetrics and Gynecology|September 10, 2005
Characterization of vaginal microflora of healthy, nonpregnant women by chaperonin-60 sequence-based methodsJanet E Hill, Swee Han Goh, Deborah M Money, et al.
JAMA Oncology|December 23, 2017
Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non-Small Cell Lung Carcinoma: A Systematic Review and Meta-analysisChee Khoon Lee, Johnathan Man, Sally Lord, et al.
Plos One|October 25, 2024
Internal evaluation of medical programs is more than housework: A scoping reviewSujani Kodagoda Gamage, Tanisha Jowsey, Jo Bishop, et al.
The Lancet. Oncology|August 2, 2005
What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?Belinda Thewes, Bettina Meiser, Vlatka M Duric, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-AnalysisChee Khoon Lee, Yi-Long Wu, Pei Ni Ding, et al.
Data in Brief|September 21, 2020
An intensive multilocation temporal dataset of fungal and bacterial communities in the root and rhizosphere of <i>Brassica napus</i>Navid Bazghaleh, Jennifer K Bell, Steven D Mamet, et al.
Histopathology|September 7, 2016
Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare targetChristina I Selinger, Bob T Li, Nick Pavlakis, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Palliative & Supportive Care|February 7, 2015
A preliminary study to develop an intervention to facilitate communication between couples in advanced cancerJane Mowll, Elizabeth A Lobb, Lisbeth Lane, et al.
Asia-Pacific Journal of Clinical Oncology|December 14, 2011
Randomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancerPaul L Mitchell, Adam Broad, Mark A Rosenthal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2016
Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non-Small Cell Lung CancerPei Ni Ding, Sarah J Lord, Val Gebski, et al.
American Journal of Obstetrics and Gynecology|September 10, 2005
Characterization of vaginal microflora of healthy, nonpregnant women by chaperonin-60 sequence-based methodsJanet E Hill, Swee Han Goh, Deborah M Money, et al.
JAMA Oncology|December 23, 2017
Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non-Small Cell Lung Carcinoma: A Systematic Review and Meta-analysisChee Khoon Lee, Johnathan Man, Sally Lord, et al.
Plos One|October 25, 2024
Internal evaluation of medical programs is more than housework: A scoping reviewSujani Kodagoda Gamage, Tanisha Jowsey, Jo Bishop, et al.
The Lancet. Oncology|August 2, 2005
What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?Belinda Thewes, Bettina Meiser, Vlatka M Duric, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-AnalysisChee Khoon Lee, Yi-Long Wu, Pei Ni Ding, et al.
Data in Brief|September 21, 2020
An intensive multilocation temporal dataset of fungal and bacterial communities in the root and rhizosphere of <i>Brassica napus</i>Navid Bazghaleh, Jennifer K Bell, Steven D Mamet, et al.
Histopathology|September 7, 2016
Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare targetChristina I Selinger, Bob T Li, Nick Pavlakis, et al.
Pageof 5